Added to YB: 2024-10-29
Pitch date: 2024-10-26
NSIS-B.CO [bullish]
Novonesis A/S
-9.57%
current return
Author Info
Kontra Investment Xchange is trying to build wealth by investing in good companies and letting those investments compound over many years. Sign up for the newsletter.
Company Info
Novonesis A/S produces and sells industrial enzymes, microorganisms, and probiotics in Denmark, rest of Europe, North America, Asia Pacific, the Middle East, Africa, Latin America, and internationally.
Market Cap
DKK 26.9B
Pitch Price
DKK 437.23
Price Target
N/A
Dividend
0.93%
EV/EBITDA
36.65
P/E
56.81
EV/Sales
9.41
Sector
Chemicals
Category
growth
10 Companies for the next 10 years - Novonesis A/S
NSIS-B.CO: Global biosolutions leader post Novozymes-Chr. Hansen merger. 2 divisions: Food & Health (46% sales) and Planetary Health (54%). Strong customer relations, broad toolbox, scalable production. 8-9% EBITDA CAGR 2023-2028. Well-positioned for sustainability/health trends.
Read full article (1 min)